Thoma Bravo announces investment in medication intelligence firm Bluesight
Prominent software investment firm, Thoma Bravo, has announced the conclusion of a strategic growth investment in Bluesight, a renowned Medication Intelligence Company. The undisclosed financial investment is set to bolster Bluesight’s drug diversion prevention solutions through its procurement of Medacist, a leader in drug diversion monitoring. Furthermore, the deal is projected to expand Bluesight’s inventory […]